Global Cord Blood Corp operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Global Cord Blood Corp with three other
health care providers in Asia:
Cedar Company Ltd
sales of 15.13 billion Japanese Yen [US$144.51 million]
of which 70%
was Facility Service),
Charm Care Corp
(19.62 billion Japanese Yen [US$187.37 million]
of which 100%
was Nursing care business), and
Thomson Medical Group Ltd
based in SINGAPORE
(218.53 million Singapore Dollars [US$160.92 million]
of which 64%
was Hospital Services).
Global Cord Blood Corp reported sales of 1.22 billion Chinese Renmimbi (US$182.66 million)
March of 2020.
increase of 23.8%
versus 2019, when the company's sales were 986.75 million Chinese Renmimbi.
Sales at Global Cord Blood Corp have increased during each of the previous five years
(and since 2015, sales have increased a total of 92%).